Addition of or switch to insulin therapy in people treated with glucagon-like peptide-1 receptor agonists: A real-world study in 66 583 patients-Reference-Cited by-同舟云学术

Addition of or switch to insulin therapy in people treated with glucagon-like peptide-1 receptor agonists: A real-world study in 66 583 patients

Published:2016-10-18 Issue:1 Volume:19 Page:108-117
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Montvida Olga¹²,Klein Kerenaftali¹,Kumar Sudhesh³,Khunti Kamlesh⁴,Paul Sanjoy K.¹

Affiliation:

1. Clinical Trials and Biostatistics Unit; QIMR Berghofer Medical Research Institute; Brisbane Australia

2. School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Faculty of Health; Queensland University of Technology; Brisbane Australia

3. Warwick Medical School; University of Warwick, and University Hospitals Coventry and Warwickshire; Coventry UK

4. Diabetes Research Centre, Leicester Diabetes Centre; University of Leicester; Leicester UK

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12790/fullpdf

Reference27 articles.

1. Intensive glucose control and macrovascular outcomes in type 2 diabetes;Turnbull;Diabetologia,2009

2. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1 · 9 million people;Shah;Lancet Diabetes Endocrinol,2015

3. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association;Fox;Circulation,2015

4. Standards of medical care in diabetes-2015;American Diabetes Association;Diabetes Care,2015

5. The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study;Paul;Cardiovasc Diabetol,2015

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment intensification following glucagon-like peptide-1 receptor agonist in type 2 diabetes: Comparative effectiveness analyses between free vs. fixed combination of GLP-1 RA and basal insulin. RESTORE-G real-world study;Nutrition, Metabolism and Cardiovascular Diseases;2024-08

2. Open questions on basal insulin therapy in T2D: a Delphi consensus;Acta Diabetologica;2024-05-20

3. Therapy of Type 2 Diabetes;Experimental and Clinical Endocrinology & Diabetes;2024-04-10

4. Therapie des Typ-2-Diabetes;Die Diabetologie;2024-01-30

5. The Basis for Weekly Insulin Therapy: Evolving Evidence With Insulin Icodec and Insulin Efsitora Alfa;Endocrine Reviews;2024-01-16